Patent ID: 9168295
Filing Date: 2015-10-27
Classification: A61K,A61P,C07K,G01N

Abstract:
1. A pharmaceutical formulation comprising a pharmaceutically acceptable carrier or diluent, a preservative, and, as the only therapeutic ingredients: the polypeptide which consists of the sequence of SEQ ID NO: 1; the polypeptide which consists of the sequence of SEQ ID NO: 2; the polypeptide which consists of the sequence of SEQ ID NO: 3; the polypeptide which consists of the sequence of SEQ ID NO: 4; the polypeptide which consists of the sequence of SEQ ID NO: 5; the polypeptide which consists of the sequence of SEQ ID NO: 6; and the polypeptide which consists of the sequence of SEQ ID NO: 7, wherein each said polypeptide is present in an amount of 100 ng to 2 mg.